Comparison of Long- and Short-acting Diuretics in Congestive Heart Failure

NCT00355667 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2016-08-18

No results posted yet for this study

Summary

The purpose of this study is to compare therapeutic effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting one, in patients with heart failure, and to test our hypothesis that long-acting diuretics are superior to short-acting types in heart failure.

Conditions

  • Congestive Heart Failure

Interventions

DRUG

furosemide

Patients with chronic heart failure receive furosemide and other standard treatment/

DRUG

azosemide

Patients with chronic heart failure receive azosemide and other standard treatment.

Sponsors & Collaborators

  • Ministry of Health, Labour and Welfare, Japan

    collaborator OTHER_GOV
  • Hyogo Medical University

    lead OTHER

Principal Investigators

  • Tohru Masuyama, MD, PhD · Cardiovascular Division, Hyogo College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00355667 on ClinicalTrials.gov